An update on the clinical pharmacology of the dipeptidyl peptidase 4 inhibitor alogliptin used for the treatment of type 2 diabetes mellitus-Reference-Cited by-同舟云学术

An update on the clinical pharmacology of the dipeptidyl peptidase 4 inhibitor alogliptin used for the treatment of type 2 diabetes mellitus

Published:2015-11-19 Issue:12 Volume:42 Page:1225-1238
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharmacol Physiol

Author:

Chen Xiao-Wu¹,He Zhi-Xu²,Zhou Zhi-Wei³,Yang Tianxin⁴,Zhang Xueji⁵,Yang Yin-Xue⁶,Duan Wei⁷,Zhou Shu-Feng²³

Affiliation:

1. Department of General Surgery; The First People's Hospital of Shunde; Southern Medical University; Shunde Foshan Guangdong China

2. Guizhou Provincial Key Laboratory for Regenerative Medicine; Stem Cell and Tissue Engineering Research Center & Sino-US Joint Laboratory for Medical Sciences; Guiyang Medical University; Guiyang Guizhou China

3. Department of Pharmaceutical Sciences; College of Pharmacy; University of South Florida; Tampa FL USA

4. Department of Internal Medicine; University of Utah and Salt Lake Veterans Affairs Medical Center; Salt Lake City UT USA

5. Research Center for Bioengineering and Sensing Technology; University of Science and Technology Beijing; Beijing China

6. Department of Colorectal Surgery; General Hospital of Ningxia Medical University; Yinchuan Ningxia China

7. School of Medicine; Deakin University; Waurn Ponds Vic. Australia

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1440-1681.12469/fullpdf

Reference94 articles.

1. The many faces of diabetes: A disease with increasing heterogeneity;Tuomi;Lancet,2014

2. Diabetes in Asia: Epidemiology, risk factors and pathophysiology;Chan;JAMA,2009

3. Clinical practice. Diagnosis of diabetes;Inzucchi;N. Engl. J. Med.,2012

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Role of Dipeptidyl Peptidase−4 in Regulating Mitochondria and Oxidative Stress in Cardiomyocytes;Cardiovascular Toxicology;2024-07-02

2. Identification of two novel dipeptidyl peptidase-IV inhibitory peptides from sheep whey protein and inhibition mechanism revealed by molecular docking;Food Bioscience;2022-08

3. The anti-diabetic drug alogliptin induces vasorelaxation via activation of Kv channels and SERCA pumps;European Journal of Pharmacology;2021-05

4. Safety, Pharmacokinetics, and Pharmacodynamics of a Dipeptidyl Peptidase‐4 Inhibitor: A Randomized, Double‐Blinded, Placebo‐Controlled Daily Administration of Fotagliptin Benzoate for 14 Days for Type 2 Diabetes Mellitus;Clinical Pharmacology in Drug Development;2021-01-13

5. Introduction of Diabetes Mellitus and Future Prospects of Natural Products on Diabetes Mellitus;Structure and Health Effects of Natural Products on Diabetes Mellitus;2021